M. Matias

发表

Homocysteine and risk of cardiovascular disease among postmenopausal women.

J. Manson, P. Ridker, J. Buring, 1999, JAMA.

Potential interference by antineutrophil cytoplasmic autoantibodies in myeloperoxidase immunoassays.

S. Datwyler, J. Shih, M. Matias, 2008, Clinical chemistry.

C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis.

C. Gibson, J. Shih, P. Moriarty, 2001, Atherosclerosis.

Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations.

C. Mueller, M. Möckel, S. Datwyler, 2008, Clinical chemistry.

Prevalence of detectable biotin in five US emergency department patient cohorts.

L. Sokoll, Ian L. Gunsolus, M. Matias, 2021, Clinical biochemistry.

Evaluation of the Abbott ARCHITECT Toxo IgM assay.

M. Hausmann, U. Sagel, M. Matias, 2009, Diagnostic microbiology and infectious disease.

Identification and characterization of new antigenic fragments related to carcinoembryonic antigen in adult feces.

R. Paxton, J. Shively, H. Rittenhouse, 1992, Cancer research.

IgA With altered carbohydrate structure as a tumor‐associated marker in serum of cancer patients

H. Rittenhouse, M. Matias, J. Tomita, 1988 .

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

P. Ridker, J. Buring, C. Hennekens, 1998, Circulation.

Homocysteine and risk of cardiovascular disease among postmenopausal women.

J. Manson, P. Ridker, C. Hennekens, 1999, JAMA.